Patents Examined by Kartic Padmanabhan
  • Patent number: 6641993
    Abstract: Apparatus and a method for mixing a liquid within a disposable aspirating probe tip so that most of the liquid is forced to move past a transition zone between two different inside diameters to cause rotational mixing. The apparatus and method can be used to provide agglutination of blood, which in turn can be used for blood typing. The probe tip can comprise a single integral piece, or two separate portions. The transition zone can comprise a sharp demarcation between inside diameters, or a smooth one.
    Type: Grant
    Filed: February 22, 2000
    Date of Patent: November 4, 2003
    Assignee: Ortho Clinical Diagnostics, Inc.
    Inventors: Merrit N. Jacobs, Zhong Ding, Ronald F. Brookes
  • Patent number: 6635420
    Abstract: The invention concerns a method for the purification of a target substance from a biological sample by immobilizing the target substance on a solid phase by means of a high affinity binding pair and subsequently eluting it by adding a partner of the binding pair in a free form. In addition reagent kits for carrying out the method are disclosed.
    Type: Grant
    Filed: October 13, 2000
    Date of Patent: October 21, 2003
    Assignee: Roche Diagnostics GmbH
    Inventors: Wolfgang Hosel, Helmut Lenz, Jochen Peter
  • Patent number: 6627396
    Abstract: A sensor for the detection of tetrameric multivalent neuraminidase within a sample is disclosed, where a positive detection indicates the presence of a target virus within the sample. Also disclosed is a trifunctional composition of matter including a trifunctional linker moiety with groups bonded thereto including (a) an alkyl chain adapted for attachment to a substrate, (b) a fluorescent moiety capable of generating a fluorescent signal, and (c) a recognition moiety having a spacer group of a defined length thereon, the recognition moiety capable of binding with tetrameric multivalent neuraminidase.
    Type: Grant
    Filed: October 27, 2000
    Date of Patent: September 30, 2003
    Assignee: The Regents of the University of California
    Inventors: Basil I. Swanson, Xuedong Song, Clifford Unkefer, Louis A. Silks, III, Jurgen G. Schmidt
  • Patent number: 6617116
    Abstract: Assay devices, kits, and methods for detection of one or more analytes in a sample are provided. The assay device features the controlled release of reagents and hence is particularly suitable for binding assays such as immunoassays. The assay device achieves greater sensitivity than conventional rapid test assays, leading to stronger and/or more stable visual signals than those produced by conventional devices, easier interpretation of results, and reduced occurrence of indeterminate results. The device can be used for detecting analyte in a variety of biological samples without the need for conventional sample filtration techniques, and thus is suitable for use by untrained personnel without specialized equipment. In addition, the device can be used to simultaneously analyze a number of analytes using a single sample.
    Type: Grant
    Filed: January 25, 2001
    Date of Patent: September 9, 2003
    Assignee: Genelabs Diagnostics Pte. Ltd.
    Inventors: Ming Guan, Hsiao Ying Chen
  • Patent number: 6613582
    Abstract: The present application describes novel uses of ruthenium bipyridyls or palladium porphyrins as photo-activatable crosslinking agents. Crosslinking can be between any two molecules including peptides, proteins, or compounds. Crosslinking occurs in the presence of an electron donor such as ammonium persulfate, and requires only moderate intensity visible light. Crosslinking can be between peptides, polypeptides or lead candidate compounds to unknown target molecules. Reagents utilyzing ruthenium bipyridyls and palladium porphyrins crosslinkers for use in diagnostic and detection scenarios are also disclosed.
    Type: Grant
    Filed: May 25, 2000
    Date of Patent: September 2, 2003
    Assignee: Board of Regents, The University of Texas System
    Inventors: Thomas J. Kodadek, David A. Fancy, Stephen A. Johnston
  • Patent number: 6610496
    Abstract: A method for predicting animal growth performance, which includes administering a suitable amount of growth hormone releasing hormone (GHRH) to an animal, observing levels of growth hormone (GH) subsequent to GHRH administration and; predicting growth and fat development in an the animal from observed levels of GH.
    Type: Grant
    Filed: July 8, 1999
    Date of Patent: August 26, 2003
    Assignee: University of Maryland, College Park
    Inventors: Geoffrey E. Dahl, Scott M. Barao, Erin E. Connor
  • Patent number: 6602661
    Abstract: The present invention is directed to a device and a method for detecting biomolecules in a tissue section or other two-dimensional sample by creating “carbon copies” of the biomolecules eluted from the sample and visualizing the biomolecules on the copies using antibodies or DNA probes having specific affinity for the biomolecules of interest. Thin membranes in a stacked or layered configuration are applied to the sample, such as a tissue section, and reagents and reaction conditions are provided so that the biomolecules are eluted from the sample and transferred onto each of the stacked membranes thereby producing multiple replicas of the biomolecular content of the sample.
    Type: Grant
    Filed: November 20, 2000
    Date of Patent: August 5, 2003
    Assignees: 20/20 GeneSystems, Inc., The United States of America as represented by the Department of Health and Human Services
    Inventors: Vladimir Knezevic, Michael R. Emmert-Buck
  • Patent number: 6602716
    Abstract: A method and device for fluorimetric determination of a biological, chemical or physical parameter of a sample utilize at least two different luminescent materials, the first of which is sensitive to the parameter, at least with respect to luminescence intensity, and the second of which is insensitive to the parameter, at least with respect to luminescence intensity and decay time. The luminescent materials have different decay times. The time- or phase behaviour of the resulting luminescence response is used to form a reference value for determination of a parameter.
    Type: Grant
    Filed: April 10, 2000
    Date of Patent: August 5, 2003
    Assignee: PreSens Precision Sensing GmbH
    Inventor: Ingo Klimant
  • Patent number: 6599756
    Abstract: Methods of detecting antibodies to one or more glycosphingolipid(s) of interest in a sample are disclosed which comprise using a solid-phase reactant having carbonyl groups attached thereon, and the glycosphingolipid(s) of interest linked to the solid-phase reactant by an amide bond between an amino group of the glycosphingolipid of interest and a carbonyl group attached to the solid-phase reactant. The methods of detecting antibodies to glycosphingolipid(s) of interest can be used in methods of diagnosing autoimmune diseases in an individual.
    Type: Grant
    Filed: July 27, 2000
    Date of Patent: July 29, 2003
    Assignee: Athena Diagnostics, Inc.
    Inventors: Normand J. Robichaud, Louis P. Kertiles
  • Patent number: 6589756
    Abstract: The invention provides improved immunoassay techniques for detecting the presence of analytes in a liquid sample. The present immunoassay methods utilize anti-allotypic monoclonal antibodies as capture reagents for primary binding proteins specific for the analytes of interest. The monoclonal antibodies are highly specific for the allotypic determinants present on the primary binding protein. The use of anti-allotypic monoclonal antibodies as capture reagents provides improved levels of specificity and accuracy of the immunoassay, in part because interference from endogenous immunoglobulins in the sample is significantly reduced. The invention further provides anti-allotypic monoclonal antibodies.
    Type: Grant
    Filed: September 15, 2000
    Date of Patent: July 8, 2003
    Assignee: Bayer Corporation
    Inventor: Eve H. Barlow
  • Patent number: 6589731
    Abstract: A sensor element is provided including a polymer exhibiting a measurable property from the group of luminescence and electrical conductivity, the polymer being complexed with a unit including a recognition element, a tethering element and a property-altering element bound thereto so as to alter the measurable property, the unit being susceptible of subsequent separation from the polymer upon exposure to an agent having an affinity for binding to the recognition element whereupon the separation of the unit from the polymer results in a detectable change in the measurable property.
    Type: Grant
    Filed: May 4, 2000
    Date of Patent: July 8, 2003
    Assignee: The Regents of the University of California
    Inventors: Liaohai Chen, Duncan W. McBranch, Hsing-Lin Wang, David G. Whitten
  • Patent number: 6582912
    Abstract: A device for dosing at least a particular constituent in a product sample has a receptacle and a cover assembled to form a closed container having a vertical axis. The receptacle and cover bear coaxial cylindrical walls defining concentric annular chambers inside the container, the walls separating chambers each having an opening, the cover and the container being rotatable relative to each other about the vertical axis, said openings being placed in a predetermined manner so that by relative displacement of the walls, the openings are positioned in a straight line or offset to communicate, or isolate said successive chambers. A method for using such a device and an apparatus for implementing said method are disclosed.
    Type: Grant
    Filed: August 14, 2000
    Date of Patent: June 24, 2003
    Assignee: Stago International
    Inventors: Alain Rousseau, Michel Canton
  • Patent number: 6579719
    Abstract: This invention provides methods of retentate chromatography for resolving analytes in a sample. The methods involve adsorbing the analytes to a substrate under a plurality of different selectivity conditions, and detecting the analytes retained on the substrate by desorption spectrometry. The methods are useful in biology and medicine, including clinical diagnostics and drug discovery.
    Type: Grant
    Filed: June 19, 1998
    Date of Patent: June 17, 2003
    Assignee: Ciphergen Biosystems, Inc.
    Inventors: T. William Hutchens, Tai-Tung Yip
  • Patent number: 6576460
    Abstract: The present invention relates to a filtration-detection device for detecting or quantifying an analyte in a test sample including a filtration device having a first binding material immobilized thereto, wherein the first binding material is capable of binding to a portion of the analyte, and a detection assembly positioned relative to the filtration device to detect or quantify analyte bound to the first binding material. The present invention also relates to methods of using the filtration-detection device.
    Type: Grant
    Filed: October 27, 2000
    Date of Patent: June 10, 2003
    Assignees: Cornell Research Foundation, Inc., Innovative Biotechnologies International, Inc.
    Inventors: Antje J. Baeumner, Richard A. Montagna
  • Patent number: 6576430
    Abstract: Methods for detection and analysis of allosteric receptor/ligand binding by changes in surface refractive index are provided. When analyzed by surface plasmon resonance, binding of such allosteric binding agents to their ligands may result in a negative deviation in the optical response (i.e., a decrease in resonance angle) or in an increase in the optical response (i.e., an increase in resonance angle) depending on the binding properties of the selected allosteric receptor. Other methods for analysis of surface refractive index are also useful in the invention. The methods of the invention are particularly useful for small ligands which would not be expected to produce detectable changes in refractive index because they do not add significant mass upon binding.
    Type: Grant
    Filed: November 20, 2000
    Date of Patent: June 10, 2003
    Assignee: Becton, Dickinson and Company
    Inventors: Helen V. Hsieh, J. Bruce Pitner, Jason E. Gestwicki
  • Patent number: 6576429
    Abstract: An apparatus for taking an intestinal sample of a human or animal patient comprises a holder part (1) and an expandable part (2) supported by the holder part and having one or more sampling areas (8) on the surface thereof. The expandable part (2) is in a non-expanded state rectally insertable into and retractable from the patient's intestine, and in an expanded state, inserted into the patient's intestine, the expandable part is capable of contacting the intestinal wall with at least one sampling area (8; 14). The apparatus further comprises protective livers (7a, 7b) for preventing said sampling area or areas (8) from contact with the intestinal wall and intestinal fluid at least when the expandable part (2) in the non-expanded state is being rectally inserted into the patient's intestine.
    Type: Grant
    Filed: October 26, 2000
    Date of Patent: June 10, 2003
    Assignee: Alimenta Diagnostics AB
    Inventor: Roger Hällgren
  • Patent number: 6573039
    Abstract: The invention relates to an optical system for determining the distribution, environment, or activity of fluorescently labeled reporter molecules in cells for the purpose of screening large numbers of compounds for specific biological activity. The invention involves providing cells containing fluorescent reporter molecules in an array of locations and scanning numerous cells in each location with a fluorescent microscope, converting the optical information into digital data, and utilizing the digital data to determine the distribution, environment or activity of the fluorescently labeled reporter molecules in the cells. The array of locations may be an industry standard 96 well or 384 well microtiter plate or a microplate which is a microplate having a cells in a micropaterned array of locations. The invention includes apparatus and computerized method for processing, displaying and storing the data.
    Type: Grant
    Filed: August 29, 2000
    Date of Patent: June 3, 2003
    Assignee: Cellomics, Inc.
    Inventors: R. Terry Dunlay, D. Lansing Taylor
  • Patent number: 6555391
    Abstract: This invention relates methods for conditioning affinity chromatography resins to decrease leaching of the ligand during purification. The methods involve incubating the resin in a buffered solution of a hydroxyalkylamine compound (e.g., ethanolamine) prior to use of the resin for an affinity purification. The treatment removes unstably bound ligand from the resin.
    Type: Grant
    Filed: August 15, 2000
    Date of Patent: April 29, 2003
    Assignee: Baxter International, Inc.
    Inventors: Susan L. Bernhard, Robert Toso, Van Taiariol
  • Patent number: 6534270
    Abstract: Disclosed are biochips having a high detecting sensitivity with readiness in fabrication of microarray, and a method for fabricating the same, in which a solid support wound with fibers is immersed in a solution containing biomolecules to immobilize the biomolecules onto the fiber, and the individual fibers with the biomolecules immobilized thereon are straightened and arranged. The arranged fibers are embedded with a defined material and cut in a direction perpendicular to the lengthwise arrangement direction of the fibers to obtain thin chips. The chips are placed on a substrate to remove the material used for embedding and thereby remain fibers with the immobilized biomolecules on the substrate. This biochip fabrication method immobilizes a great number of biomolecules onto the fibers having a large surface area to enhance the detection sensitivity and allows production of a great number of substrates with an array of biomolecules immobilized simultaneously.
    Type: Grant
    Filed: April 12, 2001
    Date of Patent: March 18, 2003
    Assignee: LG Electronics Inc.
    Inventors: Su Hyeon Kim, Je Kyun Park, Tae Han Kim
  • Patent number: 6534282
    Abstract: A method to assess hypertension by measuring the amount of free and conjugated hydroxyeicosatrienoic acids (DHETs) and metabolites of DHETs, which are metabolites of arachidonic acid (AA) epoxygenases and epoxide hydrolases, in a biological sample which contains the DHETs (using any methods including GC/MS or ELISA) is disclosed. The method further included determining the amount of molecules containing a DHET-specific epitope immunoreactive with antibodies produced against DHETs present in the sample. This amount is compared with a control sample(s). Hypertension is determined through the comparison wherein the amount of increase of free and conjugated DHETs and metabolites of DHETs in the sample isolated from an organism. The present invention also provides a method to assess catalytic activity of AA epoxygenases using immunoassays by subtracting the amounts of NADPH-independent epoxyeicosatriencic acids (EETs) from total (NADPH-dependent+independent) EETs.
    Type: Grant
    Filed: September 4, 2001
    Date of Patent: March 18, 2003
    Inventors: Hyesook Kim, Jorge H. Capdevila, Raymond R. Novak, Deanna Kroetz